🇺🇸 FDA
Patent

US 7807640

Orally administered peptides synergize statin activity

granted A61KA61K31/22A61K31/366

Quick answer

US patent 7807640 (Orally administered peptides synergize statin activity) held by The Regents of the University of California expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/22, A61K31/366, A61K31/40, A61K31/405